newsfilter
← Latest News
GlobeNewswire·

Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering

NORTHBROOK, Ill., April 27, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (NASDAQ:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and w